Voisin Consulting CH
Voisin Consulting CH is recorded as a service provider in 8 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 8 of 8 trials · Latest update first
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy of a Single Intravenous Dose of SGT-003 in Ambulant Males With Duchenne Muscular Dystrophy
Sponsor Solid Biosciences Inc.
- Start (EU)
- Not reported
- Latest update
- Estimated end
Phase 1/2, Open Label, Sequential Cohort Study of a Single Intracranial Dose of rAAVOlig001-ASPA Gene Therapy for Treatment of Children with Typical Canavan Disease
Sponsor Myrtelle Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase 1/2, Multicenter, Open-Label Study to Investigate the Safety, Tolerability, and Efficacy of a Single Intravenous Dose of SGT-003 in Males with Duchenne Muscular Dystrophy
Sponsor Solid Biosciences Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Dementia with Lewy Bodies (DLB)
Sponsor Eip Pharma Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase 2 Study of Intratumoral Injection of LTX-315 in Combination with Pembrolizumab in Patients with Percutaneously Accessible Lesions with Advanced Melanoma Refractory to PD-1/PD-L1 Inhibitor Therapy
Sponsor Lytix Biopharma AS
- Start (EU)
- Latest update
- Estimated end
Long-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector
Sponsor Genetix Biotherapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
Longterm Follow-up of Subjects with Cerebral Adrenoleukodystrophy Who Were Treated with Lenti-D Drug Product
Sponsor Genetix Biotherapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
Long-Term Follow-up of Subjects With Transfusion-Dependant β-Thalassemia Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector
Sponsor Genetix Biotherapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Voisin Consulting CH?
The 2026-10-09 snapshot links Voisin Consulting CH to 8 distinct CTIS trials. Recorded services include Regulatory services, Clinical monitoring, Data management, Electronic data capture, among 9 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Voisin Consulting CH?
The most frequently recorded therapeutic areas are Genetic and Congenital Disorders, Neurology, Musculoskeletal, Metabolic Disorders. Recorded phases include Phase 1, Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Voisin Consulting CH conducted?
The linked trials record locations in 8 countries, including France, Italy, Germany, Netherlands, Spain. These are trial locations, not confirmed office locations or countries where Voisin Consulting CH delivered services.
What can this page tell me about Voisin Consulting CH's trial experience?
Browse 8 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 2 recorded name variants under Voisin Consulting CH. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Voisin Consulting CH S.a.r.l.
- Voisin Consulting CH SARL